<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01182818</url>
  </required_header>
  <id_info>
    <org_study_id>FD01/2010</org_study_id>
    <nct_id>NCT01182818</nct_id>
  </id_info>
  <brief_title>Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease</brief_title>
  <acronym>FASEP</acronym>
  <official_title>FASEP Fabry and Stroke Epidemiological Protocol RISK FACTORS IN ISCHEMIC STROKE PATIENTS WITH FABRY DISEASE AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rostock</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rostock</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      More than one million people in Europe suffer from a stroke every day. Normally older people&#xD;
      have a stroke, but also a significant number of younger people between 18 and 55 years.&#xD;
      Usually, these can only be explained for a minority by the classical risk factors such as&#xD;
      diabetes, overweight and high blood pressure. New studies indicate that in about 1 - 2 % of&#xD;
      the younger stroke patients the etiology can be an undiagnosed genetic disease, e.g. Fabry&#xD;
      disease. Fabry disease is a lysosomal storage disorder known to cause vasculopathy. The&#xD;
      purpose of this study is to determine in a large number of young stroke patients, how many&#xD;
      strokes were caused by Fabry disease and what risk factors might be able to predict this&#xD;
      disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1000</enrollment>
  <condition>Cerebrovascular Accident</condition>
  <condition>Stroke, Acute</condition>
  <condition>Cerebral Stroke</condition>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <description>all adult patients (18 - 60 years of age) with an acute cerebrovascular event of any etiology</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Fabry diagnostic will be done centrally: blood samples will be stored for analysis of&#xD;
      a-galactosidase in blood, Gb3 as well as lyso-Gb3. In all cases direct analysis of the gene&#xD;
      will be done, especially in females where due to the Lyonisation effect a-galactosidase&#xD;
      activity might be normal in blood although the patient might suffer from Fabry disease.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with acute ischemic cerebrovascular event of any ischemic etiology&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (18 - 60 years of age) with an acute ischemic cerebrovascular event&#xD;
             either acute ischemic stroke or transient ischemic attack within 10 days&#xD;
&#xD;
          -  Diagnosis of the cerebrovascular event (CVE) by a stroke experienced physician&#xD;
&#xD;
          -  Diagnostic procedures for CVE according to the local guidelines and recommendations&#xD;
&#xD;
          -  Written informed consent from patient or legal representative according to local&#xD;
             regulations&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients being younger than 18 years or older than 60 years of age.&#xD;
&#xD;
          -  Acute ischemic stroke or transient ischemic attack longer than 10 days before&#xD;
             enrollment into the study&#xD;
&#xD;
          -  CVE associated with intracranial hemorrhage as evidenced by cerebral CT scan&#xD;
&#xD;
          -  Any uncertainty in the diagnosis&#xD;
&#xD;
          -  No written informed consent from the patient or legal representative&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arndt Rolfs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rostock, Albrecht-Kossel-Institute for Neuroregeneration</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurology, Kreiskrankenhaus Altenburg</name>
      <address>
        <city>Altenburg</city>
        <zip>04600</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. of Neurology, Vivantes Netzwerk für Gesundheit GmbH, Klinikum Neukölln</name>
      <address>
        <city>Berlin</city>
        <zip>12351</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Allgemeines Krankenhaus Celle</name>
      <address>
        <city>Celle</city>
        <zip>29223</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Klinikum Chemnitz gGmbH</name>
      <address>
        <city>Chemnitz</city>
        <zip>09131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heinrich-Heine University Duesseldorf, Dept. of Neurology</name>
      <address>
        <city>Duesseldorf</city>
        <zip>D-40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Giessen, Department of Neurology</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology S10, Universitaetsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universität Heidelberg, Klinik für Neurologie</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Universitaetsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <zip>07740</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. of Neurology, Ökumenisches Hainich Klinikum gGmbH</name>
      <address>
        <city>Mühlhausen / Thürigen</city>
        <zip>99974</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Regensburg, Klinik für Neurologie</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rostock, Department of Neurology</name>
      <address>
        <city>Rostock</city>
        <zip>D-18055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Ulm, Department of Neurology</name>
      <address>
        <city>Ulm</city>
        <zip>D-89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Psychiatry and Neurology, Dept. of Neurology</name>
      <address>
        <city>Warsaw</city>
        <zip>02-957</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Poland</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Croatia</country>
    <country>France</country>
    <country>Portugal</country>
    <country>Spain</country>
  </removed_countries>
  <verification_date>June 2012</verification_date>
  <study_first_submitted>August 16, 2010</study_first_submitted>
  <study_first_submitted_qc>August 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2010</study_first_posted>
  <last_update_submitted>June 13, 2012</last_update_submitted>
  <last_update_submitted_qc>June 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rostock</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Arndt Rolfs</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Cerebrovascular Accident</keyword>
  <keyword>Cerebrovascular Accident, Acute</keyword>
  <keyword>Fabry Disease</keyword>
  <keyword>Fabry´s Disease</keyword>
  <keyword>Anderson-Fabry Disease</keyword>
  <keyword>CVA (Cerebrovascular Accident)</keyword>
  <keyword>Stroke, Acute</keyword>
  <keyword>Cerebral Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Fabry Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

